FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Do More to Promote Generic Competition: White Paper

[ Price : $8.95]

A Brookings Institution white paper lists six policy changes FDA could make to enhance generic drug competition.

Califf on Tweaking Accelerated Approvals, No Big Revamp

[ Price : $8.95]

FDA commissioner Robert Califf says a total revamp of the drug accelerated approval program is not needed to answer criticism foll...

Whole-of-Governments Approach to Illicit Medical Products

[ Price : $8.95]

FDA says it is working with the Organization of Economic Cooperation and Development on a whole-of-governments approach to fightin...

FDA to Study Breast Implant Risk Perception

[ Price : $8.95]

FDA says it is funding a study of patient perceptions of the risk of a specific cancer associated with textured breast implants.

Panel Backs Moderna Covid Vaccine in Children

[ Price : $8.95]

An FDA advisory committee votes unanimously (22 to 0) to recommend the agency grant Moderna an emergency use authorization for its...

ICH Draft Quality Risk Management Guidance

[ Price : $8.95]

FDA publishes a draft International Council for Harmonization guidance on quality risk management with no new regulatory expectati...

Notice Corrected on Donor Eligibility Requirements

[ Price : $8.95]

Federal Register notice: FDA corrects a 5/24 notice on a draft guidance being made available entitled "Blood Pressure and Pulse Do...

Pfizer, Moderna Vaccines Safe & Effective in Children: FDA

[ Price : $8.95]

As FDA prepares for a 6/14-15 advisory committee meeting on pediatric Covid-19 vaccines, agency briefing documents find the Pfizer...

Comments Extended on Antimicrobial Drug Use

[ Price : $8.95]

Federal Register notice: FDA extends the comment period for a 2/16 notice that requested comments on antimicrobial drug use practi...

FDA OKs Cancer Drugs Faster/Sooner Than EMA: Study

[ Price : $8.95]

A new JAMA online study finds that FDA reviews and approves new oncology therapies much faster and sooner than the EMA.